Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Ranolazine for Angina in Hypertrophic Cardiomyopathy
View through CrossRef
Ranolazine is an antianginal and works by inhibiting late-sodium current (INaL). However, its use is limited mostly to patients with coronary artery disease. However, literature has shown its potential benefit in relieving angina in hypertrophic cardiomyopathy. Hereby, we discuss two cases where ranolazine led to improvement in angina refractory to beta-blockers. In conclusion, ranolazine can be considered as a potential antianginal drug in patients with hypertrophic cardiomyopathy refractory to beta-blockers.
Title: Ranolazine for Angina in Hypertrophic Cardiomyopathy
Description:
Ranolazine is an antianginal and works by inhibiting late-sodium current (INaL).
However, its use is limited mostly to patients with coronary artery disease.
However, literature has shown its potential benefit in relieving angina in hypertrophic cardiomyopathy.
Hereby, we discuss two cases where ranolazine led to improvement in angina refractory to beta-blockers.
In conclusion, ranolazine can be considered as a potential antianginal drug in patients with hypertrophic cardiomyopathy refractory to beta-blockers.
Related Results
Ranolazine-Tacrolimus Interaction
Ranolazine-Tacrolimus Interaction
Objective:
To report the case of a kidney allograft recipient on a stable regimen of tacrolimus who exhibited increased tacrolimus concentrations within 24 hour...
Program «Smart ECG – ranolazin» - own experience and world approach
Program «Smart ECG – ranolazin» - own experience and world approach
Purpose - comprehensive analysis of the world approach of the use of ranolazine in various clinical trials and the introduction of the program "Smart ECG" to assess the effectivene...
Diagnostic capabilities of cardiac computed tomography in the preoperative diagnosis of hypertrophic cardiomyopathy
Diagnostic capabilities of cardiac computed tomography in the preoperative diagnosis of hypertrophic cardiomyopathy
BACKGROUND: A comprehensive approach to studying hypertrophic cardiomyopathy with diagnostic equipment and the latest scanning methods will ensure quality control and effective tre...
Comparative Analysis of the Coronary Arteries Flow Pattern in Secondary Myocardial Hypertrophies and by Sarcomeric Mutation
Comparative Analysis of the Coronary Arteries Flow Pattern in Secondary Myocardial Hypertrophies and by Sarcomeric Mutation
Background: Coronary flow with a diastolic predominance increases two to five times in hyperemia, mediated by vasodilation (coronary flow reserve, CFR) and, in hypertrophy, relativ...
A Rare Neurological Complication of Ranolazine
A Rare Neurological Complication of Ranolazine
Myoclonus is not a known side effect of ranolazine. We report a case of myoclonus in a 72-year-old female who underwent cardiac catheterization for angina and was started on ranola...
Current management of hypertrophic cardiomyopathy
Current management of hypertrophic cardiomyopathy
ABSTRACT
Hypertrophic cardiomyopathy is a common yet under-recognized genetic structural heart condition characterized by left ventricular hypertrophy. Patients m...
A Case of Takotsubo Cardiomyopathy Following Postpartum Hemorrhage in a Patient with Concurrent Influenza A
A Case of Takotsubo Cardiomyopathy Following Postpartum Hemorrhage in a Patient with Concurrent Influenza A
Background
Takotsubo cardiomyopathy, also known as stress cardiomyopathy and broken heart syndrome, is a transient, non-ischemic cardiomyopathy marked by revers...
P1001Efficacy of ranolazine for the prevention of atrial fibrillation in high-risk patients with chronic coronary syndrome and hypertension
P1001Efficacy of ranolazine for the prevention of atrial fibrillation in high-risk patients with chronic coronary syndrome and hypertension
Abstract
Background
Ranolazine currently is used to relief angina symptoms in patients with chronic coronary syndrome (CCS). Add...